drugset / Trial / NCT00117468

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

NCT00117468

Phase 2 Completed 20 enrolled Duramed Research
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-center, open-label, randomized, active-controlled study to compare DR-2011 to progesterone vaginal gel for luteal phase replacement.

Timeline

Start
2005-06
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DR-2011 Unknown Other
Comparator Progesterone Other / unclassified 8 % Other

Indications